APA

Duchesne G. M., Woo H. H., Bassett J. K., Bowe S. J., D'Este C., Frydenberg M., King M., Ledwich L., Loblaw A., Malone S., Millar J., Milne R., Smith R. G., Spry N., Stockler M., Syme R. A., Tai K. H. & Turner S. (20170605). Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial. : The Lancet. Oncology.

Chicago

Duchesne Gillian M, Woo Henry H, Bassett Julie K, Bowe Steven J, D'Este Catherine, Frydenberg Mark, King Madeleine, Ledwich Leo, Loblaw Andrew, Malone Shawn, Millar Jeremy, Milne Roger, Smith Rosemary G, Spry Nigel, Stockler Martin, Syme Rodney A, Tai Keen Hun and Turner Sandra. 20170605. Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial. : The Lancet. Oncology.

Harvard

Duchesne G. M., Woo H. H., Bassett J. K., Bowe S. J., D'Este C., Frydenberg M., King M., Ledwich L., Loblaw A., Malone S., Millar J., Milne R., Smith R. G., Spry N., Stockler M., Syme R. A., Tai K. H. and Turner S. (20170605). Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial. : The Lancet. Oncology.

MLA

Duchesne Gillian M, Woo Henry H, Bassett Julie K, Bowe Steven J, D'Este Catherine, Frydenberg Mark, King Madeleine, Ledwich Leo, Loblaw Andrew, Malone Shawn, Millar Jeremy, Milne Roger, Smith Rosemary G, Spry Nigel, Stockler Martin, Syme Rodney A, Tai Keen Hun and Turner Sandra. Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial. : The Lancet. Oncology. 20170605.